UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 17, 2022
Accession Number:0001193125-22-286773
Submission Type:POS AM
CIK:0001696396
Company Name:Stealth BioTherapeutics Corp
File Number:333-237542